GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (WBO:BAX) » Definitions » Change In Payables And Accrued Expense

Baxter International (WBO:BAX) Change In Payables And Accrued Expense : €484 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Baxter International Change In Payables And Accrued Expense?

Baxter International's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was €10 Mil. It means Baxter International's Accounts Payable & Accrued Expense increased by €10 Mil from Sep. 2023 to Dec. 2023 .

Baxter International's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €476 Mil. It means Baxter International's Accounts Payable & Accrued Expense increased by €476 Mil from Dec. 2022 to Dec. 2023 .


Baxter International Change In Payables And Accrued Expense Historical Data

The historical data trend for Baxter International's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baxter International Change In Payables And Accrued Expense Chart

Baxter International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -197.10 117.55 276.12 -277.54 475.92

Baxter International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -129.33 233.50 61.84 178.97 10.09

Baxter International Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €484 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baxter International Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Baxter International's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Baxter International (WBO:BAX) Business Description

Traded in Other Exchanges
Address
One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.